TY - JOUR
T1 - γ-secretase directly sheds the survival receptor BCMA from plasma cells
AU - Laurent, Sarah A.
AU - Hoffmann, Franziska S.
AU - Kuhn, Peer Hendrik
AU - Cheng, Qingyu
AU - Chu, Yuanyuan
AU - Schmidt-Supprian, Marc
AU - Hauck, Stefanie M.
AU - Schuh, Elisabeth
AU - Krumbholz, Markus
AU - Rübsamen, Heike
AU - Wanngren, Johanna
AU - Khademi, Mohsen
AU - Olsson, Tomas
AU - Alexander, Tobias
AU - Hiepe, Falk
AU - Pfister, Hans Walter
AU - Weber, Frank
AU - Jenne, Dieter
AU - Wekerle, Hartmut
AU - Hohlfeld, Reinhard
AU - Lichtenthaler, Stefan F.
AU - Meinl, Edgar
N1 - Publisher Copyright:
© 2015 Macmillan Publishers Limited. All rights reserved.
PY - 2015/6/11
Y1 - 2015/6/11
N2 - Survival of plasma cells is regulated by B-cell maturation antigen (BCMA), a membrane-bound receptor activated by its agonist ligands BAFF and APRIL. Here we report that γ-secretase directly cleaves BCMA, without prior truncation by another protease. This direct shedding is facilitated by the short length of BCMA's extracellular domain. In vitro, γ-secretase reduces BCMA-mediated NF-kB activation. In addition, γ-secretase releases soluble BCMA (sBCMA) that acts as a decoy neutralizing APRIL. In vivo, inhibition of γ-secretase enhances BCMA surface expression in plasma cells and increases their number in the bone marrow. Furthermore, in multiple sclerosis, sBCMA levels in spinal fluid are elevated and associated with intracerebral IgG production; in systemic lupus erythematosus, sBCMA levels in serum are elevated and correlate with disease activity. Together, shedding of BCMA by γ-secretase controls plasma cells in the bone marrow and yields a potential biomarker for B-cell involvement in human autoimmune diseases.
AB - Survival of plasma cells is regulated by B-cell maturation antigen (BCMA), a membrane-bound receptor activated by its agonist ligands BAFF and APRIL. Here we report that γ-secretase directly cleaves BCMA, without prior truncation by another protease. This direct shedding is facilitated by the short length of BCMA's extracellular domain. In vitro, γ-secretase reduces BCMA-mediated NF-kB activation. In addition, γ-secretase releases soluble BCMA (sBCMA) that acts as a decoy neutralizing APRIL. In vivo, inhibition of γ-secretase enhances BCMA surface expression in plasma cells and increases their number in the bone marrow. Furthermore, in multiple sclerosis, sBCMA levels in spinal fluid are elevated and associated with intracerebral IgG production; in systemic lupus erythematosus, sBCMA levels in serum are elevated and correlate with disease activity. Together, shedding of BCMA by γ-secretase controls plasma cells in the bone marrow and yields a potential biomarker for B-cell involvement in human autoimmune diseases.
UR - http://www.scopus.com/inward/record.url?scp=84931291652&partnerID=8YFLogxK
U2 - 10.1038/ncomms8333
DO - 10.1038/ncomms8333
M3 - Article
C2 - 26065893
AN - SCOPUS:84931291652
SN - 2041-1723
VL - 6
JO - Nature Communications
JF - Nature Communications
M1 - 7333
ER -